See The Whole Board: The Inflation Reduction Act of 2022 and the complex chess game now in play for pharmaceutical manufacturers

Make sense of the complicated chessboard that is the US health care system and understand the impact that the Inflation Reduction Act of 2022 will have across almost every aspect, from increased regulations for evidence and cost effectiveness to a total overhaul of pipeline and clinical development strategies. 

Access informed analysis and strategies for moving ahead. Download your free Insight brief for an inside look at:

• The players in US health care
• The impact of the Inflation Reduction Act on Medicare
• Wide-ranging impacts of new laws
• Navigating long-range cause and effect pathways
• And more